Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Magnetic Resonance Spectroscopy × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 13 Glioma 12 Neoplasm Metastasis 11 Lymphoma 10 Glioblastoma 10 Neuroblastoma 9 Lung Neoplasms 8 Carcinoma, Renal Cell 8 Brain Neoplasms 8 Medulloblastoma 7 Ovarian Neoplasms 6 Neoplasms 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Fallopian Tube Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Rectal Neoplasms 5 Osteosarcoma 5 Neuroendocrine Tumors 5 Melanoma 5 Ependymoma 5 Central Nervous System Neoplasms 5 Wilms Tumor 4 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Rhabdoid Tumor 4

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡